About: Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)
Creator	Kanamori, Hajime Fischer, William Rutala, William Weber, David Sickbert-Bennett, Emily
source	Elsevier; Medline; PMC
abstract	Over the past several decades, we have witnessed the emergence of many new infectious agents, some of which are major public threats. New and emerging infectious diseases which are both transmissible from patient-to-patient and virulent with a high mortality include novel coronaviruses (SARS-CoV, MERS-CV), hemorrhagic fever viruses (Lassa, Ebola), and highly pathogenic avian influenza A viruses, A(H5N1) and A(H7N9). All healthcare facilities need to have policies and plans in place for early identification of patients with a highly communicable diseases which are highly virulent, ability to immediately isolate such patients, and provide proper management (e.g., training and availability of personal protective equipment) to prevent transmission to healthcare personnel, other patients and visitors to the healthcare facility.
has issue date	2016-05-02(xsd:dateTime)
bibo:doi	10.1016/j.ajic.2015.11.018
bibo:pmid	27131142
has license	els-covid
sha1sum (hex)	4e5ad9b4c6397ca3a08494096cd224621999460e
schema:url	https://doi.org/10.1016/j.ajic.2015.11.018
resource representing a document's title	Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)
has PubMed Central identifier	PMC7132650
has PubMed identifier	27131142
schema:publication	American Journal of Infection Control
resource representing a document's body	covid:4e5ad9b4c6397ca3a08494096cd224621999460e#body_text
is schema:about of	named entity 'Respiratory' named entity 'Middle East' named entity 'MIDDLE EAST RESPIRATORY SYNDROME' named entity 'INFLUENZA VIRUSES' named entity 'FOCUS' named entity 'RESPIRATORY' named entity 'ISSUES' named entity 'ACUTE' named entity 'SYNDROME' named entity 'INFECTION CONTROL' named entity 'EBOLA' named entity 'EMERGING INFECTIOUS DISEASES' named entity 'CORONAVIRUSES' named entity 'HEMORRHAGIC FEVER VIRUSES' named entity 'NOVEL' named entity 'HIGHLY PATHOGENIC AVIAN INFLUENZA' named entity 'H5N1' named entity 'Respiratory' named entity 'Middle East Respiratory Syndrome' named entity 'Emerging infectious diseases' named entity 'Ebola' named entity 'coronaviruses' named entity 'MERS-CoV' named entity 'Pneumonia' named entity 'Republic of Korea' named entity 'methicillin-resistant Staphylococcus aureus' named entity 'viral disease' named entity 'Asia' named entity 'Sierra Leone' named entity 'aerosolization' named entity 'neuraminidase inhibitors' named entity 'West Africa' named entity 'health care facilities' named entity 'body fluids' named entity 'reservoir host' named entity 'vomit' named entity 'SARS' named entity 'microbes' named entity 'bird flu' named entity 'microbial' named entity 'Middle East' named entity 'influenza viruses' named entity 'goggles' named entity 'food supplies' named entity 'disinfectant' named entity 'personal protective equipment' named entity 'influenza' named entity 'infection' named entity 'β-lactamase' named entity 'MERS' named entity 'Ebola' named entity 'Ebola' named entity 'infection control' named entity 'quarantine' named entity 'respiratory symptoms' named entity 'H9N2' named entity 'United Kingdom' named entity 'epidemiology' named entity 'influenza' named entity 'PCR' named entity 'H7N2' named entity 'Infection' named entity 'SARS' named entity 'Republic of Korea' named entity 'fomite' named entity 'infection' named entity 'electronic medical record' named entity 'H1N1' named entity 'September 24, 2015' named entity 'disinfectant' named entity 'Sierra Leone' named entity 'coronavirus' named entity 'Junin virus' named entity 'Convalescent plasma' named entity 'Ebola' named entity 'hygiene' named entity 'Russia'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software